George A. Samuel Iii.

Companies

• Lineage Cell TherapeuticsGeneral counsel Sep 2, 2021 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Lineage Cell Therapeutics LCTX31,063 shares²$29.4K at $0.95Feb 11, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 11, 2026Shares withheld for tax 2,502 shares at $1.80 of Lineage Cell Therapeutics²
• Feb 11, 2026Exercised options 6,075 shares of Lineage Cell Therapeutics²
• Dec 19, 2025Shares withheld for tax 65 shares at $1.68 of Lineage Cell Therapeutics³
• Dec 19, 2025Granted 1,735 shares of Lineage Cell Therapeutics³
• Feb 11, 2025Shares withheld for tax 2,440 shares at $0.65 of Lineage Cell Therapeutics⁴
• Feb 11, 2025Exercised options 6,076 shares of Lineage Cell Therapeutics⁴
• Nov 26, 2024Bought 15,000 shares at $0.60 of Lineage Cell Therapeutics⁵
• Feb 11, 2024Shares withheld for tax 2,490 shares at $1.08 of Lineage Cell Therapeutics⁶
• Feb 11, 2024Exercised options 6,076 shares of Lineage Cell Therapeutics⁶
• Feb 11, 2023Shares withheld for tax 2,478 shares at $1.35 of Lineage Cell Therapeutics⁷
• Feb 11, 2023Exercised options 6,076 shares of Lineage Cell Therapeutics⁷